<DOC>
	<DOCNO>NCT00443040</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy asimadoline patient undergone laparoscopic segmental colectomy determine whether reduces time recovery bowel function compare placebo .</brief_summary>
	<brief_title>Asimadoline Treatment Post-Operative Ileus</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study design evaluate efficacy tolerability two dose level asimadoline duration post-operative ileus subject undergo laparoscopic hand-assisted laparoscopic colon resection . Subjects meet entry criterion randomize 1:1:1 ratio receive either asimadoline 1.0 mg , asimadoline 3.0 mg placebo . One hundred fourteen subject plan , event subject convert laparoscopic surgery open surgery ( laparotomy ) , subject would discontinue trial follow safety . The protocol allow subject convert open procedure replace . The first dose administer approximately 90 minute pre-operatively , subsequent dosing b.i.d . 10 post-operative dos . Subjects dose study drug hospital . After discharge , follow additional 28 day . Total study duration patient approximately 5 6 week .</detailed_description>
	<mesh_term>Ileus</mesh_term>
	<criteria>Males female age 1880 Must schedule undergo laparoscopic/handassisted laparoscopic segmental colectomy Must sign ICF Females childbearing potential must negative pregnancy test screen Subjects evidence biochemical structural abnormality GI tract comorbid illness may impact ability interpret safety efficacy data Pregnant breastfeeding female Use investigational drug previous 30 day Refusal discontinue prohibit concomitant medication Chronic use prescription narcotic previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>